Overview
Hello Heart offers a digital therapeutics program for cardiovascular health, including a free blood pressure monitor and an app that helps people track heart-related metrics for eligible employees and members through employers and health plans as a covered benefit (B2B2C). Users pair the blood pressure monitor with the app to track blood pressure, cholesterol, and medication intake, receiving personalized insights and coaching based on behavioral science to manage heart health. The program differentiates itself by combining hardware (free BP monitor) with cardiovascular-focused digital therapeutics and coaching delivered via a scalable B2B2C model, emphasizing cardiovascular risk management and employer cost savings rather than generic wellness apps. The goal is to improve population heart health while reducing healthcare costs for employers by preventing and better managing chronic cardiovascular conditions through technology, monitoring hardware, and behavioral coaching.
Work here?Claim your company
Simplify's take
What believers are saying
- Committed annual recurring revenue grew 50% in 2025, with similar 2026 growth expected.
- August 19, 2026 study found $7,000 lower medical spend for heart-failure users.
- Inc. 5000 named Hello Heart among North America's fastest-growing private companies in 2026.
What critics are saying
- Employers can drop benefits fast if savings underperform or engagement erodes.
- Navitus and Aetna-style channel partners can commoditize distribution and squeeze margins.
- If a major payer cancels in 2027, Hello Heart's employer-only revenue base becomes fragile.
What makes Hello Heart unique
- Hello Heart's AI models flag near-term cardiovascular risk up to 90 days ahead.
- It bundles connected devices, coaching, and medication support into one employer benefit.
- March 3, 2026 ACC collaboration strengthens clinical credibility with cardiology buyers.
Help us improve and share your feedback! Did you find this helpful?